Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of GOSS will decline by -0.95% over the next 2 Weeks and hit $0.16 by Thursday, September 3, 2026. In that time frame, GOSS's share price is expected to range between $0.13 and $0.18.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 3, 2026 | 0.13 | 0.16 | 0.18 |
| Sep 2, 2026 | 0.14 | 0.16 | 0.18 |
| Sep 1, 2026 | 0.13 | 0.16 | 0.18 |
| Aug 31, 2026 | 0.13 | 0.15 | 0.17 |
| Aug 28, 2026 | 0.13 | 0.15 | 0.17 |
| Aug 27, 2026 | 0.13 | 0.16 | 0.18 |
| Aug 26, 2026 | 0.13 | 0.16 | 0.18 |
| Aug 25, 2026 | 0.13 | 0.15 | 0.18 |
| Aug 24, 2026 | 0.13 | 0.15 | 0.18 |
| Aug 21, 2026 | 0.13 | 0.15 | 0.17 |
GOSS shares fell -1.78% in Friday, August 21, 2026's trading session, dropping from a previous close of $0.16 to move at $0.15. The stock demonstrated notable intraday movement (see GOSS's key stats for a full breakdown), fluctuating between $0.15 and $0.17, a +16.90% trading range. While recent weeks have seen some volatility, GOSS has managed to secure a -12.15% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 130.03M shares changing hands, 123.33M more than the previous session. This amounted to $20.12M in total market activity.
Will GOSS Continue Its Upward Trend?
According to analyst ratings and projections for GOSS, Gossamer Bio, Inc. shares are anticipated to increase by +13.94%, potentially reaching $0.18 per share by September 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for GOSS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the GOSS stock forecast, now is a good time to buy GOSS stock because its current trading price is -0.83% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on GOSS covering social and institutional perspectives.
GOSS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into GOSS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.01% to 44.42%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 38.68%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 41.85%, maintains a neutral outlook for the long term. Insights into GOSS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Gossamer Bio Short-Term Forecasts
GOSS Forecast For Next 5 Days
Our algorithm anticipates Gossamer Bio (GOSS) stock could hit $0.19 by Aug 28, 2026. This represents a +20.56% rise from today's price, following a +3.17% change over the past five days.
GOSS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Gossamer Bio, Inc. (GOSS) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.17, which would mean a +9.89% increase from the current price of $0.15. Projections for this period range from a high of $0.22 to a low of $0.13.
GOSS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Gossamer Bio's price over the next three months point to a drop. GOSS stock is expected to peak at $0.13 on Aug 28, 2026 before potentially dipping to $0.00 on Nov 20, 2026. On average, GOSS is likely to trade around $0.02 in the coming 90 days.
Gossamer Bio Stock Forecast 2025
Based on our predictive models, Gossamer Bio (GOSS) is expected to trade between $0.00 and $0.13 throughout 2026. This would result in an average price of $0.02, potentially offering investors a -87.07% return from current levels.
Gossamer Bio, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Gossamer Bio, Inc. (GOSS) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $0.13, settling at an average of $0.05. This could translate to a -67.68% loss.
September 2026
Based on current market signals, Gossamer Bio, Inc. is projected to trend september 2026. We forecast a trading range from $0.00 to $0.12, with a likely average price of $0.04. Investors could expect a potential return of -74.14%.
October 2026
Our predictive algorithms indicate Gossamer Bio, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$0.09, with an average target of $0.01. This represents a cautious outlook and a possible loss of -93.54%.
November 2026
Analyzing established trends, Gossamer Bio, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $0.08, averaging around $0.00. This suggests a -100.00% loss from current levels.
December 2026
Market indicators suggest Gossamer Bio, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $0.08, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
January 2027
Forecasting for January 2027, models estimate that Gossamer Bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.07, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
February 2027
According to our latest forecast models, Gossamer Bio, Inc. (GOSS) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $0.07, settling at an average of $0.00. This could translate to a -100.00% loss.
March 2027
Based on current market signals, Gossamer Bio, Inc. is projected to trend march 2027. We forecast a trading range from $0.00 to $0.07, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
April 2027
Our predictive algorithms indicate Gossamer Bio, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$0.07, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
May 2027
Analyzing established trends, Gossamer Bio, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $0.07, averaging around $0.00. This suggests a -100.00% loss from current levels.
June 2027
Market indicators suggest Gossamer Bio, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $0.07, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
July 2027
Forecasting for July 2027, models estimate that Gossamer Bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.08, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
August 2027
According to our latest forecast models, Gossamer Bio, Inc. (GOSS) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $0.07, settling at an average of $0.00. This could translate to a -100.00% loss.
GOSS's history of dividends and stock splits also plays a role in long-term investor confidence.